Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Huixin Qi
A Novel PI3K Inhibitor PIK-C98 Displays Potent Preclinical Activity Against Multiple Myeloma
Oncotarget
Oncology
Involvement of CYP4F2 in the Metabolism of a Novel Monophosphate Ester Prodrug of Gemcitabine and Its Interaction Potential in Vitro
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Related publications
A Novel Selective Small-Molecule PI3K Inhibitor Is Effective Against Human Multiple Myeloma in Vitro and in Vivo
Blood Cancer Journal
Oncology
Hematology
Activity of TAS4464, a Novel NEDD8 Activating Enzyme E1 Inhibitor, Against Multiple Myeloma via Inactivation of NF‐κB Pathways
Cancer Science
Cancer Research
Medicine
Oncology
BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
Preclinical Animal Models of Multiple Myeloma
BoneKEy Reports
TAS0728, a Covalent-Binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Preclinical Evaluation of a Novel Triple-Acting PIM/PI3K/mTOR Inhibitor, IBL-302, in Breast Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
Preclinical Antitumor Activity of SST0116CL1: A Novel Heat Shock Protein 90 Inhibitor
International Journal of Oncology
Cancer Research
Oncology
P2.13-32 TAK-788 Is a Novel and Potent Tyrosine Kinase Inhibitor With Selective Activity Against EGFR/HER2
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Generation of Potent Antitumor CTL From Patients With Multiple Myeloma Directed Against HM1.24
Clinical Cancer Research
Cancer Research
Oncology
